Measurable Residual Disease Assessed by Flow-Cytometry Is a Stable Prognostic Factor for Pediatric T-Cell Acute Lymphoblastic Leukemia in Consecutive SEHOP Protocols Whereas the Impact of Oncogenetics Depends on Treatment

Nerea Vega‐García, Mireia Camós, Elena Esperanza‐Cebollada et al.|Frontiers in Pediatrics|2021

Cited by 9